Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:monoclonal_antibody
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Immuno_Gen
gptkb:Immuno_Gen,_Inc. |
| gptkbp:activities |
delivers cytotoxic agent to cancer cells
|
| gptkbp:clinical_trial |
Phase 3
|
| gptkbp:developed_by |
gptkb:Immuno_Gen,_Inc.
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mirvetuximab soravtansine
|
| gptkbp:is_used_for |
treatment of ovarian cancer
|
| gptkbp:manager |
intravenous
|
| gptkbp:operational_status |
under review
|
| gptkbp:social_structure |
Ig G1 antibody
|
| gptkbp:targets |
Folate receptor alpha
|
| gptkbp:type |
gptkb:monoclonal_antibody
|